Home
>
Chemicals Market Price & Insight
>
Ofloxacin Market Price & Analysis
>
Ofloxacin Featured News
Ofloxacin Featured News
143 items
-
21
OctThe supply chain crisis has spread to the Korean pharmaceutical industry, and many drugs are 'out of stock'
On October 20 (CCTV Finance "Tianxia Finance") In South Korea, the global supply chain crisis also affected many industries. -
19
OctZhengzhou People's Pharmaceutical has a total investment of 130 million yuan in the rifamycin bio-fermentation series product project settled in Kailu
On October 15, the signing ceremony for the rifamycin bio-fermentation series product project between Kailu County and Zhengzhou Minsheng Pharmaceutical Co., Ltd. -
28
SepZhejiang Puluojiayuan Pharmaceutical Co., Ltd. 'Made in Zhejiang' brand product successfully passed the supervision and review
Recently, Zhejiang Puluojiayuan Pharmaceutical Co., Ltd., a subsidiary of Puluo Pharmaceutical Co., Ltd.'s "Made in Zhejiang" brand product -
26
SepNational Development and Reform Commission: Adhere to the five major work principles to promote energy consumption 'dual control'
On the 17th, the National Development and Reform Commission's WeChat public account released the relevant responsible comrades to answer reporters' questions on the "Plan for Improving the Dual Control System -
26
SepAfter the transformation of Datong Tongxing Antibiotics Company, the environmental tax in the first half of 2021 is only 13,600 yuan
In recent years, the Taxation Bureau of Datong City, Pingcheng District of the State Administration of Taxation has actively promoted the implementation of the green tax system -
24
SepThe 30,000 tons (refined M and DM) project of Dongying Pingming Pharmaceutical's cephalosporin intermediates will be put into production soon
On September 22, Dongying Pingming Pharmaceutical Technology Co., Ltd.'s annual production of 30,000 tons of pharmaceutical intermediates project construction site rumbling in the production workshop -
23
SepCangzhou Fanbo Fine Chemical Co., Ltd. rebuilds an antiviral drug intermediate and API production project with an annual output of 4,500 tons
Project name: 4,500 tons of pharmaceutical intermediates and APIs rebuilding and production project -
16
SepRecently, a symposium on the demand for the addition of Shijiazhuang pharmaceutical import ports was held
On September 13, Liu Xiaohan, secretary of the Hebei Pharmaceutical Industry Association, and Mao Yuming, executive deputy secretary-general of the Hebei Pharmaceutical Industry Association -
16
SepHongshan District Emergency Management Bureau hired experts to conduct safety inspections on Chifeng Pharmaceutical
From September 2 to September 5, the District Emergency Management Bureau hired national industry experts to conduct a 4-day safety inspection on Chifeng Pharmaceutical Co., Ltd. -
16
SepTwo people were killed in a flash explosion accident in a pilot project of a pharmaceutical intermediate factory in Jilin
Recently, a pilot project of Jilin Purui Te Biotechnology Co., Ltd. in Jilin Economic and Technological Development Zone of Jilin City, Jilin Province -
9
SepZhejiang Chuangxin Environmental Protection signed a contract with Lukang Pharmaceutical to help resource utilization of pharmaceutical and chemical wastewater
In August 2021, Zhejiang Kaichuang Environmental Protection Technology Co., Ltd. successfully signed a domestic antibiotic production leader-Shandong Lukang Pharmaceutical Co., Ltd. -
7
SepPrologue has established three engineering technology platforms for fluid chemistry, crystals and powders, and biocatalysis
Recently, Puluo Pharmaceuticals held an engineering technology platform award ceremony at Puluo College, announcing the establishment of three engineering technology platforms for fluid chemistry -
30
AugTop 100 projects in Heilongjiang Province: Lianshun Green Biomedicine Project is progressing smoothly and monomer commissioning before the end of the year
Top 100 projects in Heilongjiang Province: The Lianshun Green Biomedicine Industry Project is progressing smoothly -
27
AugPrologue Pharmaceuticals invests in the establishment of a CDMO R&D center in the United States to further enhance the competitiveness of the CDMO market
In order to further promote the "Strong CDMO" strategy, expand overseas markets, and accelerate the strategic layout of international development -
27
AugLivzon Pharmaceutical's sales revenue of key APIs and intermediates in the first half of 2021
On August 25, Livzon Pharmaceutical Group Co., Ltd. announced the results for the first half of 2021 -
19
AugThree measures of Shaoxing Municipal Market Supervision Administration to guide API companies to compete and operate in compliance
In order to implement the new requirements of the country to strengthen the regulation of competition in the pharmaceutical industry -
19
AugShaoxing City Market Supervision Administration 'Four Steps' to Build a Defense Line for Safe Production of APIs
In order to implement the spirit of General Secretary Xi Jinping’s important exposition on safe production and comprehensively improve the level of safety production management of API manufacturers -
19
AugHeilongjiang Huarui Biopharmaceutical Project does not miss epidemic prevention and control and construction, and strives to be completed and put into production as soon as possible
To ensure that the Heilongjiang Huarui Biomedical Project is completed and put into production as soon as possible, Laha Town, Laha Industrial Town Construction Investment Co., Ltd. -
19
AugNorth China Pharmaceutical's 'R&D and demonstration application of key technologies for anti-drug-resistant bacteria drug Mupirocin' successfully passed the acceptance
On August 11, 2021, the Hebei Province Science and Technology Plan Project undertaken by North China Pharmaceutical Group New Drug Research and Development Co., Ltd. -
16
AugZhejiang East Asia Pharmaceuticals achieved operating income of 345 million yuan in the first half of 2021, down 31.91% year-on-year
Zhejiang East Asia Pharmaceutical Co., Ltd. report on the performance of the first half of 2021.
To find more products about market price & insight, you can search directly below
SEARCH
Recommend Products
-
![Buy OFLOXACIN82419-36-1]( "OFLOXACIN82419-36-1")
-
![Buy Factory Wholesale Pharmaceutical Ofloxacin Powder CAS 82419-36-1 Ofloxacin for Antibacterial]( "Factory Wholesale Pharmaceutical Ofloxacin Powder CAS 82419-36-1 Ofloxacin for Antibacterial")
Factory Wholesale Pharmaceutical Ofloxacin Powder CAS 82419-36-1 Ofloxacin for Antibacterial
Cas No.: 82419-36-1
HNB Biotech
-
![Buy High purity Ofloxacin CAS NO.82419-36-1]( "High purity Ofloxacin CAS NO.82419-36-1")
-
![Buy Ofloxacin 99]( "Ofloxacin 99")
-
![Buy Metformin HCL]( "Metformin HCL")
-
![Buy supply Hot Selling 99% Metformin Hydrochloride CAS 1115-70-4 Metformin HCl]( "supply Hot Selling 99% Metformin Hydrochloride CAS 1115-70-4 Metformin HCl")
supply Hot Selling 99% Metformin Hydrochloride CAS 1115-70-4 Metformin HCl
Cas No.: 1115-70-4
Nanjing Huaman Import and Exp
-
![Buy artemisinin 63968-64-9]( "artemisinin 63968-64-9")
Breaking News
-
Urea Weekly Report (May 18, 2026 - May 24, 2026)
May 25 -
[CPE]: May 29, 2026 Shandong Market CPE Price
May 29 -
[Butadiene]: May 26, 2026 European market butadiene prices fell
May 27 -
Urea Operation Trajectory under the Background of Export (2026-05-26)
May 26 -
1,3-Butadiene Weekly Report (May 18, 2026 - May 24, 2026)
May 25 -
Propylene supply-side maintenance pattern surged in May and fell back in June.
May 27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)